A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder

Mostrar otras versiones (1)

Elevated cerebrospinal fluid (CSF) levels of the glia-derived N-methyl-D-aspartic acid receptor antagonist kynurenic acid (KYNA) have consistently been implicated in schizophrenia and bipolar disorder. Here, we conducted a genome-wide association study based on CSF KYNA in bipolar disorder and found...

Descripción completa

Detalles Bibliográficos
Autores principales: Sellgren, C M, Kegel, M E, Bergen, S E, Ekman, C J, Olsson, S, Larsson, M, Vawter, M P, Backlund, L, Sullivan, P F, Sklar, P, Smoller, J W, Magnusson, P K E, Hultman, C M, Walther-Jallow, L, Svensson, C I, Lichtenstein, P, Schalling, M, Engberg, G, Erhardt, S, Landén, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965332/
https://www.ncbi.nlm.nih.gov/pubmed/26666201
http://dx.doi.org/10.1038/mp.2015.186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965332/
https://www.ncbi.nlm.nih.gov/pubmed/26666201
http://dx.doi.org/10.1038/mp.2015.186

Ejemplares similares